| Filed On | Filing |
|---|---|
| 26 Apr 2023 | SC 13G/A |
| 13 Feb 2023 | SC 13G/A |
| 27 Jan 2023 | SC 13G |
| 14 Feb 2022 | SC 13G |
| 10 Feb 2022 | SCHEDULE 13G/A |
| 08 Feb 2022 | SEC SCHEDULE 13G |
| 02 Feb 2022 | SC 13G/A |
| 27 Jan 2022 | SC 13G/A |
| 25 Jan 2022 | SC 13G |
| 14 Jan 2022 | 15-12B |
| 06 Jan 2022 | AMENDMENT NO. 4 TO THE SCHEDULE 13D |
| 04 Jan 2022 |
Form 4: Feld Peter A, Director
Returned 2,374,798 shares to the issuer |
| 04 Jan 2022 |
Form 4: West Jeffrey N, SVP & Controller
Returned 25,692 shares to the issuer · Disposed of 5,769 Stock Options (Disposition to Issuer) · Disposed of 9,793 Restricted Stock Units (Disposition to Issuer) · 1 more |
| 04 Jan 2022 |
Form 4: Shulman Steven J, Director
Returned 27,451 shares to the issuer |
| 04 Jan 2022 |
Form 4: Sansone Guy P, Director
Returned 7,973 shares to the issuer |
| 04 Jan 2022 |
Form 4: Norwalk Leslie V, Director
Returned 5,698 shares to the issuer |
| 04 Jan 2022 |
Form 4: Murray James E, President and COO
Received 3,262 shares by exercise or conversion · Gave up 871 shares to cover exercise price or tax ($82.7K) · Returned 13,203 shares to the issuer · 3 more |
| 04 Jan 2022 |
Form 4: Mackenzie Gregory Scott, Director
Returned 10,594 shares to the issuer |
| 04 Jan 2022 |
Form 4: Lewis Clapper Caskie, Chief Human Resources Officer
Returned 19,510 shares to the issuer · Disposed of 34,338 Stock Options (Disposition to Issuer) · Disposed of 56,122 Stock Option (Disposition to Issuer) · 2 more |
| 04 Jan 2022 |
Form 4: Kamal Mostafa, CEO, Magellan Rx Management
Returned 5,994 shares to the issuer · Disposed of 51,953 Stock Options (Disposition to Issuer) · Disposed of 37,921 Restricted Stock Units (Disposition to Issuer) · 1 more |
Loading...
